Literature DB >> 29393250

Risk Factors for Distant Metastasis in Patients with Oral Cavity Squamous Cell Carcinoma Undergoing Surgical Treatment.

Felipe Toyama Aires1, Chin Shien Lin2, Leandro Luongo Matos2, Marco Aurélio Vamondes Kulcsar2, Claudio Roberto Cernea1.   

Abstract

OBJECTIVE: The aim of this study is to investigate the clinical and pathological factors related to distant metastasis in patients with oral cavity squamous cell carcinoma (OCSCC) undergoing surgery. STUDY
DESIGN: A retrospective data review was conducted on patients who underwent primary surgery for OCSCC at the Instituto do Cancer do Estado de São Paulo (ICESP) between 2009 and 2015. Distant metastasis rates were calculated and predictive factors were determined by the Cox proportional-hazards model.
RESULTS: There was a total of 274 patients, including 210 (76.6%) men and 64 (23.4%) women, with a mean age of 59.9 ± 10.9 years. The incidence of distant metastasis was 9.6%, with the lung being the most common site. The mean time interval between surgical treatment and the diagnosis of distant metastasis was 12 months (range 2-40 months). In the multivariate analysis, angiolymphatic invasion (HR = 2,87; p = 0.023), contralateral cervical metastasis (HR = 3.3; p = 0,007), tumor thickness >25 mm (HR = 3.50; p = 0.009), and locoregional recurrence (HR = 6.59; p < 0.0001) were the only independent risk factors for distant metastasis.
CONCLUSION: Patients with OCSCC who have contralateral lymph node metastasis, tumors with a thickness >25 mm, angiolymphatic invasion, or locoregional recurrence after surgical treatment have a greater risk of developing distant metastasis.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Metastasis; Oral cancer; Risk factors; Squamous cell carcinoma

Mesh:

Year:  2018        PMID: 29393250     DOI: 10.1159/000485627

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  7 in total

1.  Distant metastasis in oral squamous cell carcinoma: Does the neutrophil-to-lymphocyte ratio act as a surrogate of the host immune status?

Authors:  Daniella Karassawa Zanoni; Cristina Valero; Marlena R McGill; Pablo H Montero; Jatin P Shah; Richard J Wong; Ian Ganly; Snehal G Patel
Journal:  Oral Oncol       Date:  2021-12-01       Impact factor: 5.972

2.  Distribution of Metastatic Nodes in N0-1 Patients with Tonsillar Squamous Cell Carcinoma and Its Implications for Selective Neck Dissection.

Authors:  Hugo Fontan Köhler; Sérgio Altino Franzi; Fernando Augusto Soares; Humberto Torloni; Luiz Paulo Kowalski
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-09-01

3.  FGF8 induces epithelial-mesenchymal transition and promotes metastasis in oral squamous cell carcinoma.

Authors:  Yilong Hao; Yanxuan Xiao; Xiaoyu Liao; Shuya Tang; Xiaoyan Xie; Rui Liu; Qianming Chen
Journal:  Int J Oral Sci       Date:  2021-03-01       Impact factor: 6.344

Review 4.  Biomarker Potential of Vimentin in Oral Cancers.

Authors:  Saie Mogre; Vidhi Makani; Swapnita Pradhan; Pallavi Devre; Shyam More; Milind Vaidya; Crismita Dmello
Journal:  Life (Basel)       Date:  2022-01-20

5.  Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3-4 oral squamous cell carcinoma.

Authors:  Kuan-Chung Ting; Tsung-Lun Lee; Wing-Yin Li; Chia-Fan Chang; Pen-Yuan Chu; Yi-Fen Wang; Shyh-Kuan Tai
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

6.  Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy.

Authors:  Yao-Yu Wu; Kai-Ping Chang; Tsung-Ying Ho; Wen-Chi Chou; Sheng-Ping Hung; Kang-Hsing Fan; Yin-Yin Chiang; Yung-Chih Chou; Ngan-Ming Tsang
Journal:  Cancer Med       Date:  2021-02-23       Impact factor: 4.452

7.  Oncogenic circDHTKD1 promotes tumor growth and metastasis of oral squamous cell carcinoma in vitro and in vivo via upregulating miR-326-mediated GAB1.

Authors:  Zhuangzhi Wu; Xiaoning He; Siqi Chen
Journal:  Braz J Med Biol Res       Date:  2021-07-16       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.